-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Pathway to improved data management in clinical trials
Wolfgang Kuchinke & Toresin Karakoyun
Conference Report: Clinical Investigation
-
Future outlook of nonpharmacological treatments for insomnia in adults: clinical trial progress
Richard R Bootzin,Rachel Manber
Editorial: Clinical Investigation
-
Future outlook of nonpharmacological treatments for insomnia in adults: clinical trial progress
Richard R Bootzin,Rachel Manber
Editorial: Clinical Investigation
-
Future outlook of nonpharmacological treatments for insomnia in adults: clinical trial progress
Richard R Bootzin,Rachel Manber
Editorial: Clinical Investigation
-
Future outlook of nonpharmacological treatments for insomnia in adults: clinical trial progress
Richard R Bootzin,Rachel Manber
Editorial: Clinical Investigation
-
Future outlook of nonpharmacological treatments for insomnia in adults: clinical trial progress
Richard R Bootzin,Rachel Manber
Editorial: Clinical Investigation
-
Future outlook of nonpharmacological treatments for insomnia in adults: clinical trial progress
Richard R Bootzin,Rachel Manber
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation